Intrapleural and intravenousCorynebacter
π
Article
π
1986
π
Springer-Verlag
π
English
β 388 KB
A prospective randomized trial compared the administration of intrapleural plus intravenous Corynebacterium parvum (C. parvum) versus placebo in patients with resected Stage I and Stage II non-small cell bronchogenic carcinoma. Treatment consisted of 7 mg C. parvum injected into the pleural space an